YOLFTbeta
06

JW Shinyak Corporation

067290 · KQ · Healthcare / Pharmaceuticals

2,335.00KRW-35.00 (-1.48%)

Price History

Full chart

Market Stats

Previous Close2,370.00
Open2,330.00
Day Range2,320.00 – 2,420.00
52-Week Range1,246.00 – 4,335.00
Volume1.79M
Market Cap165.94B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.88
50-Day Avg2,637.86
200-Day Avg2,115.23

About

JW Shinyak Corporation, a pharmaceutical company, engages in the production and sale of medicines and medical supplies in South Korea. The company offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. It also develops prostate cancer treatment, liver cancer treatment, rheumatoid arthritis treatment, etc. using immune cells. The company was founded in 1981 and is based in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOLee Gyeong Ha
  • Employees235
  • Headquarters2477, Nambusunhwan-ro, Seoul, South Korea, 137-864, Korea
  • Websitehttps://www.jw-shinyak.co.kr

Leadership

  • Lee Gyeong HaCo-Chief Exec. Officer · b. 1963
  • Jin-Hwan KimCo-Chief Exec. Officer · b. 1956
  • Dong-Yeol YuDirector of Management Planning Office and Inside Director · b. 1960

Financials

Income Statement

Currency: KRW2007-12-312008-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue23.95B26.79B70.76B69.92B70.69B73.02B76.95B83.38B76.84B91.78B102.53B103.80B100.97B102.71B104.23B93.01B81.04B
Growth (%)-+11.85%+164.12%-1.19%+1.10%+3.29%+5.38%+8.37%-7.85%+19.43%+11.72%+1.24%-2.73%+1.73%+1.48%-10.77%-12.87%
Cost of Revenue22.77B23.42B33.17B33.25B32.29B31.00B32.06B36.39B38.59B47.73B54.98B58.65B54.35B55.78B56.34B46.56B40.43B
Gross Profit-----41.35B44.88B46.99B38.26B44.05B47.55B45.15B46.62B46.93B47.90B46.46B40.61B
Gross Margin-----56.62%58.33%56.36%49.79%48.00%46.38%43.50%46.17%45.69%45.95%49.95%50.11%
Operating Expense-----37.53B40.51B40.31B41.42B46.88B47.03B46.36B43.27B42.79B83.11B36.51B33.16B
Operating Income--2.06B519.96M2.45B3.82B4.37B6.68B-3.17B-2.83B523.65M-1.21B3.34B4.14B-35.21B9.95B7.46B
Operating Margin--2.92%0.74%3.46%5.23%5.68%8.01%-4.12%-3.08%0.51%-1.17%3.31%4.03%-33.78%10.70%9.20%
EBITDA-------------7.19B-31.07B9.54B16.51B
EBITDA Margin-------------7.00%-29.80%10.26%20.37%
Net Income------527.32M255.85M-481.75M-6.08B-7.51B1.44B-6.45B883.78M1.40B-37.36B5.08B15.66B
Net Income Margin------0.72%0.33%-0.58%-7.91%-8.18%1.41%-6.21%0.88%1.36%-35.84%5.46%19.32%
R&D--1.99B-3.29B3.18B1.73B1.57B1.79B2.17B-2.59B3.13B2.61B2.90B2.46B2.02B
R&D as % of Total Revenue--2.81%-4.65%4.36%2.25%1.88%2.32%2.37%-2.50%3.10%2.54%2.79%2.64%2.49%
Interest Expense000000000001.25B1.03B1.09B1.86B1.71B721.62M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.20%1.02%1.06%1.79%1.84%0.89%

Balance Sheet

Currency: KRW2007-12-312008-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets48.85B45.27B102.79B115.25B126.32B126.99B127.68B143.61B123.36B109.21B136.85B96.33B92.00B94.09B65.62B63.04B58.24B
Total Liabilities21.37B21.24B49.99B66.14B81.38B84.53B87.45B105.01B86.53B75.72B70.71B39.77B36.56B38.12B49.17B36.14B17.51B
Total Equity27.49B24.02B52.81B49.18B45.04B42.58B40.23B38.60B36.83B33.49B66.14B56.56B55.44B55.97B16.77B26.90B40.73B
Cash2.77B520.63M1.11B718.06M783.38M916.39M1.20B1.65B1.04B1.45B29.60B3.15B1.01B2.90B19.01B7.83B62.75M
Total Debt------65.76B62.72B66.83B46.45B44.38B8.09B-----
Net Debt-----------17.35B17.39B15.63B9.46B2.13B837.25M

Cash Flow

Currency: KRW2006-12-312007-12-312008-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.96B-1.95B---2.31B-22.08M743.20M-2.50B7.40B4.31B4.10B7.77B7.13B2.56B8.44B6.03B
Investing Cash Flow-2.84B4.40B----3.02B2.96B-11.43B8.58B2.30B-8.49B8.46B-4.46B-2.55B6.10B1.73B-
Financing Cash Flow--20.36M11.80B12.52B17.53B5.30B-2.52B11.13B-6.76B-9.53B32.36B-39.39B-5.45B-2.68B7.46B-21.35B-
Capital Expenditure01.18B84.07M756.71M3.03B438.71M869.36M1.88B2.13B1.25B1.06B842.64M1.16B893.89M1.62B1.50B1.51B1.60B
Free Cash Flow------------1.94B6.78B5.50B1.06B6.93B4.43B
Dividends Paid---1.20B862.35M888.12M914.66M1.13B1.94B2.33B2.43B2.49B4.10B1.72B1.61B1.61B1.61B1.98B
FCF to OCF------------47.42%87.30%77.23%41.39%82.17%73.47%
Dividend Paid to FCF------------211.05%25.28%29.25%152.08%23.22%44.58%

Earnings

Report DateSep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Mar 18, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Feb 8, 2022May 16, 2022Aug 16, 2022Nov 14, 2022Feb 9, 2023May 15, 2023Aug 14, 2023Nov 13, 2023Feb 6, 2024May 14, 2024Aug 14, 2024Nov 11, 2024Feb 5, 2025May 8, 2025Aug 12, 2025Nov 12, 2025Dec 31, 2025May 6, 2026Jun 30, 2026
EPS Estimate---------------------------------------------------------------
EPS Actual-3.640.0010.9323.4629.85-46.0123.007.6313.14-17.43-13.31-44.3014.93-7.83-13.2127.29-16.8113.0738.906.92-53.9825.5424.97-17.28-34.46-28.003.16-16.33-73.89-4.20-7.69-7.71-115.5517.71-30.0733.994.20-71.834.1818.87-85.46-9.01-6.3329.626.0421.411.1910.31-1.1012.79-789.3528.00-24.5332.9119.51115.94-68.09160.2358.2837.221.3647.7463.92
Surprise---------------------------------------------------------------
Timing--------------------------------------------Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap165.94B
Enterprise Value178.48B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.48
Price / Book4.31
Revenue (TTM)101.57B
Gross Profit (TTM)47.61B
EBITDA8.60B
Profit Margin1.69%
Operating Margin5.03%
Return on Equity4511.02%
Return on Assets3.53%
Shares Outstanding41.55M
Shares Float30.86M
Beta0.88
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20201×
60.00Dec 29, 2020
20191×
44.77Dec 27, 2019
20181×
44.77Dec 27, 2018
20171×
44.77Dec 27, 2017
20161×
44.77Dec 28, 2016
20151×
37.31Dec 29, 2015
20141×
22.39Dec 29, 2014
20131×
18.11Dec 27, 2013
20121×
17.58Dec 27, 2012
20111×
17.07Dec 28, 2011
20101×
23.21Dec 29, 2010
20091×
23.21Dec 29, 2009
20031×
64.37Dec 29, 2003

Stock Splits

  • Dec 30, 202521:20
  • Dec 27, 202421:20
  • Dec 27, 202321:20
  • Dec 28, 202221:20
  • Dec 29, 202121:20
  • Dec 29, 202021:20
  • Dec 29, 2014103:100
  • Dec 27, 2013103:100
  • Dec 27, 2012103:100
  • Dec 28, 2011103:100
  • Dec 29, 2009103:100
  • Oct 23, 20032:1